Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated from v3.3.3; no visible changes to study details or site functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:31:31.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-12-23T10:10:20.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Publication note wording changed to indicate publications are automatically filled from PubMed, and the Revision tag was updated to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:45:51.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Tainan, Taiwan as a study site. Removed the Tainan City, Taiwan listing and the government-funding status notice from the page.
    Difference
    0.2%
    Check dated 2025-11-17T17:22:58.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    No significant changes were detected on the Study Details page for NCT03673501. The content, locations, and eligibility criteria appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T09:56:56.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    - Updated version to v3.2.0 and removed the Gastrointestinal stromal tumor resource from Genetic and Rare Diseases Information Center. - Added a government funding lapse notice with operating-status guidance for users.
    Difference
    2%
    Check dated 2025-10-05T14:29:41.000Z thumbnail image

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.